FDA Approves Journavx Drug to Treat Pain Without Addiction Risknews2025-01-31T00:12:17+00:00January 31st, 2025|The New York Times|
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Reportnews2025-01-06T10:01:00+00:00January 6th, 2025|The New York Times|
What the Polio Vaccine Has Meant for Public Healthnews2024-12-13T20:15:05+00:00December 13th, 2024|The New York Times|
Qué es la rapamicina y por qué se piensa que sirve para mantenerse jovennews2024-09-24T21:30:27+00:00September 24th, 2024|The New York Times|
Rapamycin and Anti-Aging: What to Knownews2024-09-24T15:26:30+00:00September 24th, 2024|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|